Literature DB >> 9042801

Quantitative differences in arterial morphometry define the placental bed in preeclampsia.

K A Starzyk1, C M Salafia, J C Pezzullo, J M Lage, V Parkash, L Vercruysse, M Hanssens, R Pijnenborg.   

Abstract

The purpose of this study was to quantitatively analyze normal and preeclamptic uteroplacental vasculature. Myometrial arteries from eight placental bed biopsies from uncomplicated term deliveries and 12 from proteinuric preeclampsia were characterized as uteroplacental, spiral, or basal arteries. Basal lumens within 0.2 mm radius and spiral/uteroplacental lumens within 0.4 mm radius were considered as the same artery. The biopsy area, lumen density, and arterial density (after correction for multiple lumens), lumen area, lumen perimeter, mean wall thickness, inflated diameter, and a slant factor, measuring the obliqueness of arterial transection, and ratios of lumen characteristics to mean wall thickness were analyzed. In preeclamptic cases, there were more basal lumens/mm2 and basal arteries/mm2 (P=.003, P=.03), and more spiral lumens/mm2 and spiral arteries/mm2 (P = .01, P = .03). Basal lumen area (P = .0003) and wall thickness (P = .007), and basal and spiral artery lumen perimeters and inflated diameters (for each, P = .0001, P = .048, respectively) and inflated diameter/wall ratios (P = .04, P = .05) were reduced compared with normal cases. Preeclamptic spiral and basal arteries are more tortuous or densely distributed than normal placental bed arteries, with smaller-caliber lumens and thicker walls. Failure of proper placentation may result in abnormal spatial anatomy in the placental bed. Alternatively, an anatomic variant of spiral and basal arteries may be more susceptible to hemodynamic stresses and endothelial damage and may predispose to preeclampsia.

Entities:  

Mesh:

Year:  1997        PMID: 9042801     DOI: 10.1016/s0046-8177(97)90135-0

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  6 in total

1.  miR-210 targets iron-sulfur cluster scaffold homologue in human trophoblast cell lines: siderosis of interstitial trophoblasts as a novel pathology of preterm preeclampsia and small-for-gestational-age pregnancies.

Authors:  Deug-Chan Lee; Roberto Romero; Jung-Sun Kim; Adi L Tarca; Daniel Montenegro; Beth L Pineles; Ernest Kim; JoonHo Lee; Sun Young Kim; Sorin Draghici; Pooja Mittal; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Sonia S Hassan; Chong Jai Kim
Journal:  Am J Pathol       Date:  2011-08       Impact factor: 4.307

2.  Genetic origin and proportion of basal plate surface-lining cells in normal and abnormal pregnancies.

Authors:  Karina Richani; Roberto Romero; Eleazar Soto; Jyh Kae Nien; Enola Cushenberry; Yeon Mee Kim; Jimmy Espinoza; Chong Jai Kim
Journal:  Hum Pathol       Date:  2006-10-23       Impact factor: 3.466

3.  Risk factors for uteroplacental vascular compromise and inflammation.

Authors:  Arthur M Baker; Joe M Braun; Carolyn M Salafia; Amy H Herring; Julie Daniels; Nicole Rankins; John M Thorp
Journal:  Am J Obstet Gynecol       Date:  2008-09       Impact factor: 8.661

4.  Human placental hypoxia-inducible factor-1alpha expression correlates with clinical outcomes in chronic hypoxia in vivo.

Authors:  Stacy Zamudio; Yuanhong Wu; Francesca Ietta; Alessandro Rolfo; Ashley Cross; Timothy Wheeler; Martin Post; Nicholas P Illsley; Isabella Caniggia
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

5.  Placental villous hypermaturation is associated with idiopathic preterm birth.

Authors:  Terry K Morgan; Jorge E Tolosa; Lisa Mele; Ronald J Wapner; Catherine Y Spong; Yoram Sorokin; Donald J Dudley; Alan M Peaceman; Brian M Mercer; John M Thorp; Mary Jo O'Sullivan; Susan M Ramin; Dwight J Rouse; Baha Sibai
Journal:  J Matern Fetal Neonatal Med       Date:  2012-12-12

6.  Autophagy induced by HIF1α overexpression supports trophoblast invasion by supplying cellular energy.

Authors:  Mikiko Yamanaka-Tatematsu; Akitoshi Nakashima; Naonobu Fujita; Tomoko Shima; Tamotsu Yoshimori; Shigeru Saito
Journal:  PLoS One       Date:  2013-10-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.